Royal Bank of Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Sell |
|
|||||
|
2025
Q1 | $6.16M | Buy |
|
|||||
|
2024
Q4 | $3.81M | Buy |
|
|||||
|
2024
Q3 | $4.09M | Buy |
|
|||||
|
2024
Q2 | $2.73M | Buy |
|
|||||
|
2024
Q1 | $2.19M | Sell |
|
|||||
|
2023
Q4 | $2.21M | Buy |
|
|||||
|
2023
Q3 | $1.85M | Sell |
|
|||||
|
2023
Q2 | $4.28M | Buy |
|
|||||
|
2023
Q1 | $3.75M | Buy |
|
|||||
|
2022
Q4 | $3.44M | Sell |
|
|||||
|
2022
Q3 | $3.79M | Sell |
|
|||||
|
2022
Q2 | $4.59M | Buy |
|
|||||
|
2022
Q1 | $2.68M | Buy |
|
|||||
|
2021
Q4 | $2.25M | Buy |
|
|||||
|
2021
Q3 | $1.1M | Buy |
|
|||||
|
2021
Q2 | $1.04M | Sell |
|
|||||
|
2021
Q1 | $4.55M | Buy |
|
|||||
|
2020
Q4 | $1.63M | Sell |
|
|||||
|
2020
Q3 | $2.12M | Sell |
|
|||||
|
2020
Q2 | $3.5M | Buy |
|
|||||
|
2020
Q1 | $1.02M | Sell |
|
|||||
|
2019
Q4 | $1.55M | Buy |
|
|||||
|
2019
Q3 | $742K | Sell |
|
|||||
|
2019
Q2 | $3.06M | Buy |
|
|||||
|
2019
Q1 | $1.47M | Buy |
|
|||||
|
2018
Q4 | $978K | Buy |
|
|||||
|
2018
Q3 | $642K | Buy |
|
|||||
|
2018
Q2 | $585K | Sell |
|
|||||
|
2018
Q1 | $694K | Buy |
|
|||||
|
2017
Q4 | $670K | Sell |
|
|||||
|
2017
Q3 | $764K | Buy |
|
|||||
|
2017
Q2 | $651K | Buy |
|
|||||
|
2017
Q1 | $564K | Sell |
|
|||||
|
2016
Q4 | $1.47M | Buy |
|
|||||
|
2016
Q3 | $687K | Sell |
|
|||||
|
2016
Q2 | $800K | Sell |
|
|||||
|
2016
Q1 | $931K | Sell |
|
|||||
|
2015
Q4 | $1.47M | Buy |
|
|||||
|
2015
Q3 | $890K | Buy |
|
|||||
|
2015
Q2 | $952K | Sell |
|
|||||
|
2015
Q1 | $954K | Sell |
|
|||||
|
2014
Q4 | $1.05M | Sell |
|
|||||
|
2014
Q3 | $1.09M | Sell |
|
|||||
|
2014
Q2 | $1.49M | Buy |
|
|||||
|
2014
Q1 | $701K | Buy |
|
|||||
|
2013
Q4 | $418K | Sell |
|
|||||
|
2013
Q3 | $535K | Buy |
|
|||||
|
2013
Q2 | $495K | Buy |
|